Samsara BioCapital, LLC: INVENTIVA SA (IVA): Quarterly 13F Position History
As of Q2 2026, Samsara BioCapital, LLC reported 6,314,805 shares of INVENTIVA SA (IVA), worth $23.9M and representing 2.0% of its 13F equity book. Quarter-over-quarter share count change: + 1,120,000 (+21.6%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.
- 6,314,805Shares Held (Latest Filing)
- $23.9MReported Market Value (Latest Filing)
- 2.0%Portfolio Weight (% of 13F Equity Book)
- +1,120,000Quarter-over-Quarter Share Change
- -$5.0MQuarter-over-Quarter Value Change
- 6,314,805Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,314,805 | +1,120,000 | +21.6% | $23.9M | 2.0% | $3.8 |
| Q1 2026 | 5,194,805 | 0 | – | $28.8M | 2.8% | $5.5 |
| Q4 2025 | 5,194,805 | – | – | $24.2M | 2.5% | $4.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Samsara BioCapital, LLC first disclose a IVA position in 13F-HR filings?
Samsara BioCapital, LLC first reported INVENTIVA SA (IVA) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was Samsara BioCapital, LLC's most recent quarter-over-quarter share-count change in IVA?
Between Q1 2026 and Q2 2026, Samsara BioCapital, LLC added 1,120,000 shares of IVA (+21.6%), bringing the total reported position to 6,314,805 shares at a market value of $23.9M.
Does the implied price-per-share represent Samsara BioCapital, LLC's cost basis in IVA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.